Adherence to Medical Treatment in Inflammatory Bowel Disease Patients from a Referral Center in Bahia-Brazil
Table 2
Montreal classification in Crohn’s disease patients from Salvador/BA 2017/2018.
Age at diagnosis
A1: ≤16 years
5 (4.3)
A2: 17-40 years
82 (70.7)
A3: >40 years
29 (25.0)
Location
L1: terminal ileum
21 (18.4)
L2: colon
49 (43.0)
L3: ileocolonic
44 (38.6)
L1+upper GI tract (L4)a
5 (4.4)
L2+L4
4 (3.5)
L3+L4
6 (5.3)
Behavior
B1: nonstricturing/nonpenetrating
59 (53.2)
B2: stricturing
25 (22.5)
B3: penetrating
27 (24.3)
B1+perianal disease (p)b
24 (21.6)
B2+(p)
6 (5.4)
B3+(p)
14 (12.6)
Values are presented as number (%). aUpper gastrointestinal tract modifier (L4) allows location coclassification L4 through L1 to L3. b(p) modifier perianal disease, added to B1 to B3, if concomitant perianal disease.